| Symbol | CYTK |
|---|---|
| Name | CYTOKINETICS INC |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Pharmaceutical Preparations |
| Address | 350 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA 94080 |
| Telephone | (650) 624-3000 |
| Fax | — |
| — | |
| Website | https://www.cytokinetics.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001061983 |
| Description | Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. Additional info from NASDAQ: |
Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock
Read moreMalik Fady Ibraham 🟡 adjusted position in 3.5K shares (1 derivative) of CYTOKINETICS INC (CYTK) at $77.37 Transaction Date: May 05, 2026 | Filing ID: 000051
Read more📋 WENDELL WIERENGA (Director) plans to sell 4K shares of CYTOKINETICS, INCORPORATED (at $66.05 each, total $266K) Filed: May 05, 2026 | ID: 004065
Read more📋 JOHN HENDERSON (Director) plans to sell 20K shares of CYTOKINETICS, INCORPORATED (at $66.05 each, total $1.3M) Filed: May 05, 2026 | ID: 004061
Read more📋 SUNG LEE (Officer) plans to sell 24K shares of CYTOKINETICS, INCORPORATED (at $66.05 each, total $1.6M) Filed: May 05, 2026 | ID: 004058
Read moreDirector WIERENGA WENDELL 🟡 adjusted position in 4.0K shares (1 derivative) of CYTOKINETICS INC (CYTK) at $75.00 Transaction Date: May 05, 2026 | Filing ID: 000050
Read moreLee Sung 🔴 sold 23.9K shares of CYTOKINETICS INC (CYTK) at $76.87 ($1.8M) Transaction Date: May 05, 2026 | Filing ID: 000049
Read moreDirector HENDERSON JOHN T 🟡 adjusted position in 20.0K shares (1 derivative) of CYTOKINETICS INC (CYTK) at $75.97 ($1.8M) Transaction Date: May 05, 2026 | Filing ID: 000048
Read more